9 results tagged Part D & Prescription Drugs
Insurers Push Back on Medicare Coverage for Weight-Loss Drugs
Health insurance companies are lobbying the Trump administration to reject Biden-era proposals that would expand Medicare and Medicaid prescription access to weight-loss medications such as Wegovy and Ozempic.
Medicare Drug Costs Spike as Plans Quickly Shift to Co-Insurance
It’s not just the price of eggs. Here’s why your Medicare out-of-pocket prescription costs are high in 2025.
Medicare Update: Hello, Dr. Oz. Goodbye, Weight-loss Drugs. Plus Medicare Advantage’s BIG $$$ Surprise
The Trump Administration has promised not to cut Medicare and Medicaid benefits but that doesn’t mean it’s been leaving things alone there. Here’s what’s been happening at CMS.
Medicare Drug Price Negotiations Target of Trump Executive Action
But will potential pharmaceutical tariffs nullify lower prescription costs? Plus Biden knocks DOGE Social Security job cuts.
What Delaying Small Molecule Drugs Means for Medicare Drug Price Negotiation
According to KFF’s research, the new Trump executive order on small molecule drugs could lead to higher Medicare prescription drug prices and potentially higher Medicare Part D premiums.
Medicare Executive Order Boosts Drug Industry’s Profits as Seniors Suffer: Report
The Medicare Rights Center reports that President Trump’s executive order on prescription drug pricing supports key drug industry efforts to weaken the Inflation Reduction Act’s (IRA) Medicare negotiation program, putting Medicare and beneficiary savings at risk.
Medicare Part B vs. Medicare Part D Drugs
What do I need to know about the difference between Part D and Part B medications?
Huge Medicare Changes Coming in 2026
You won't want to miss these changes announced by CMS. Plus, insights from Marcia Mantell.
Will Trump Pitch Sweeping Medicare Part D Prescription Price Plan?
POLITICO reports Trump wanted the ‘most favored nation’ policy in his first term but faced resistance from the pharmaceutical industry and the courts.